PACAP Protects Against TNFα-induced Cell Death in Olfactory Epithelium and Olfactory Placodal Cell Lines

Overview

Journal Mol Cell Neurosci

Specialties Cell Biology
Molecular Biology
Neurology

Date 2010 Jul 27

PMID 20654718

Citations 15

Authors

Shami Kanekar

Mahendra Gandham

Mary T Lucero

Affiliations

Soon will be listed here.

Abstract

In mouse olfactory epithelium (OE), pituitary adenylate cyclase-activating peptide (PACAP) protects against axotomy-induced apoptosis. We used mouse OE to determine whether PACAP protects neurons during exposure to the inflammatory cytokine TNFα. Live slices of neonatal mouse OE were treated with 40 ng/ml TNFα ± 40nM PACAP for 6h and dying cells were live-labeled with 0.5% propidium iodide. TNFα significantly increased the percentage of dying cells while co-incubation with PACAP prevented cell death. PACAP also prevented TNFα-mediated cell death in the olfactory placodal (OP) cell lines, OP6 and OP27. Although OP cell lines express all three PACAP receptors (PAC1, VPAC1,VPAC2), PACAP's protection of these cells from TNFα was mimicked by the specific PAC1 receptor agonist maxadilan and abolished by the PAC1 antagonist PACAP6-38. Treatment of OP cell lines with blockers or activators of the PLC and AC/MAPKK pathways revealed that PACAP-mediated protection from TNFα involved both pathways. PACAP may therefore function through PAC1 receptors to protect neurons from cell death during inflammatory cytokine release in vivo as would occur upon viral infection or allergic rhinitis-associated injury.

Citing Articles

Olfactory Dysfunction in Allergic Rhinitis.

Zhang X, Zhou Y, Liu Z, Liu Y Clin Rev Allergy Immunol. 2025; 68(1):3.

PMID: 39752065 DOI: 10.1007/s12016-024-09016-z.

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death.

Horvath G, Reglodi D, Fabian E, Opper B Int J Mol Sci. 2022; 23(9).

PMID: 35563353 PMC: 9100246. DOI: 10.3390/ijms23094953.

Infects Glial Cells and Invades the Central Nervous System the Olfactory and Trigeminal Nerves.

Chacko A, Delbaz A, Choudhury I, Eindorf T, Shah M, Godfrey C Front Cell Infect Microbiol. 2022; 12:793416.

PMID: 35281448 PMC: 8907725. DOI: 10.3389/fcimb.2022.793416.

Antimicrobial responses of peripheral and central nervous system glia against Staphylococcus aureus.

Choudhury I, Chacko A, Delbaz A, Chen M, Basu S, St John J Sci Rep. 2021; 11(1):10722.

PMID: 34021227 PMC: 8140078. DOI: 10.1038/s41598-021-90252-0.

Acute Systemic Experimental Inflammation Does Not Reduce Human Odor Identification Performance.

Tognetti A, Sarolidou G, Lasselin J, Lekander M, Olsson M, Lundstrom J Chem Senses. 2021; 46.

PMID: 33537776 PMC: 8015794. DOI: 10.1093/chemse/bjab004.

References

Morio H, Tatsuno I, Tanaka T, Uchida D, Hirai A, Tamura Y . Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neurotrophic factor for cultured rat cortical neurons. Ann N Y Acad Sci. 1996; 805:476-81. DOI: 10.1111/j.1749-6632.1996.tb17507.x. View

Clausen B, Lambertsen K, Babcock A, Holm T, Dagnaes-Hansen F, Finsen B . Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008; 5:46. PMC: 2585073. DOI: 10.1186/1742-2094-5-46. View

Delgado M, Abad C, Martinez C, Juarranz M, Leceta J, Ganea D . PACAP in immunity and inflammation. Ann N Y Acad Sci. 2003; 992:141-57. DOI: 10.1111/j.1749-6632.2003.tb03145.x. View

Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O . Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev. 2009; 61(3):283-357. DOI: 10.1124/pr.109.001370. View

Moro O, Wakita K, Ohnuma M, Denda S, Lerner E, Tajima M . Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J Biol Chem. 1999; 274(33):23103-10. DOI: 10.1074/jbc.274.33.23103. View

Dejda A, Sokolowska P, Nowak J . Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Rep. 2005; 57(3):307-20. View

Lerner E, Ribeiro J, Nelson R, Lerner M . Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem. 1991; 266(17):11234-6. View

Kaushal V, Schlichter L . Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008; 28(9):2221-30. PMC: 6671848. DOI: 10.1523/JNEUROSCI.5643-07.2008. View

Vaudry D, Pamantung T, Basille M, Rousselle C, Fournier A, Vaudry H . PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci. 2002; 15(9):1451-60. DOI: 10.1046/j.1460-9568.2002.01981.x. View

10.

Farbman A, Buchholz J, Suzuki Y, Coines A, Speert D . A molecular basis of cell death in olfactory epithelium. J Comp Neurol. 1999; 414(3):306-14. DOI: 10.1002/(sici)1096-9861(19991122)414:3<306::aid-cne2>3.0.co;2-#. View

11.

McCoy M, Tansey M . TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008; 5:45. PMC: 2577641. DOI: 10.1186/1742-2094-5-45. View

12.

Waschek J . Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev Neurosci. 2002; 24(1):14-23. DOI: 10.1159/000064942. View

13.

Unal-Cevik I, Kilinc M, Can A, Gursoy-Ozdemir Y, Dalkara T . Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke. 2004; 35(9):2189-94. DOI: 10.1161/01.STR.0000136149.81831.c5. View

14.

Kieffer T, Habener J . The glucagon-like peptides. Endocr Rev. 1999; 20(6):876-913. DOI: 10.1210/edrv.20.6.0385. View

15.

Shioda S, Ohtaki H, Nakamachi T, Dohi K, Watanabe J, Nakajo S . Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann N Y Acad Sci. 2006; 1070:550-60. DOI: 10.1196/annals.1317.080. View

16.

Onoue S, Endo K, Ohshima K, Yajima T, Kashimoto K . The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides. 2002; 23(8):1471-8. DOI: 10.1016/s0196-9781(02)00085-2. View

17.

Lane A, Turner J, May L, Reed R . A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci. 2010; 30(6):2324-9. PMC: 2957830. DOI: 10.1523/JNEUROSCI.4507-09.2010. View

18.

Mikkelsen J, Hannibal J, Fahrenkrug J, Larsen P, Olcese J, McArdle C . Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary. J Neuroendocrinol. 1995; 7(1):47-55. DOI: 10.1111/j.1365-2826.1995.tb00666.x. View

19.

Delgado M, Leceta J, Ganea D . Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol. 2003; 73(1):155-64. DOI: 10.1189/jlb.0702372. View

20.

Pathak N, Johnson P, Getman M, Lane R . Odorant receptor (OR) gene choice is biased and non-clonal in two olfactory placode cell lines, and OR RNA is nuclear prior to differentiation of these lines. J Neurochem. 2008; 108(2):486-97. PMC: 2737357. DOI: 10.1111/j.1471-4159.2008.05780.x. View